IQV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:04):

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific...

Stats
Today's Volume	356 842
Average Volume	955 388
Market Cap	42.87B
EPS	$0 ( 2024-04-25 )
Next earnings date	( $2.47 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	32.27
ATR14	$0.101 (0.04%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Bousbib Ari	Buy	42 847	Common Stock
2024-03-01	Bousbib Ari	Sell	16 261	Common Stock
2024-03-01	Bousbib Ari	Sell	15 417	Common Stock
2024-03-01	Bousbib Ari	Sell	11 169	Common Stock
2024-03-01	Bousbib Ari	Sell	42 847	Stock Appreciation Right

INSIDER POWER
4.80
Last 100 transactions
Buy: 392 287 \| Sell: 364 416

Volume Correlation

Long: 0.03 (neutral)

Short: 0.01 (neutral)

Signal:(49.739) Neutral

IQVIA Holdings Inc Correlation

10 Most Positive Correlations
NUVB	0.89
ADCT	0.88
BLK	0.875
IVR	0.866
RGS	0.866
SSL	0.863
MYTE	0.861
USDP	0.858
LH	0.858
BARK	0.857

10 Most Negative Correlations
CSLT	-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

IQVIA Holdings Inc Correlation - Currency/Commodity

-0.10
( neutral )

0.09
( neutral )

0.00
( neutral )

-0.13
( neutral )

0.32
( neutral )

-0.38
( neutral )

IQVIA Holdings Inc Financials

Annual	2023
Revenue:	$15.01B
Gross Profit:	$4.14B (27.56 %)
EPS:	$7.39

FY	2023
Revenue:	$15.01B
Gross Profit:	$4.14B (27.56 %)
EPS:	$7.39

FY	2022
Revenue:	$14.41B
Gross Profit:	$5.03B (34.89 %)
EPS:	$5.82

FY	2021
Revenue:	$13.87B
Gross Profit:	$4.64B (33.45 %)
EPS:	$5.05

Financial Reports:

No articles found.

IQVIA Holdings Inc

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.